Global Respiratory Distress Syndrome Market Size, Status and Forecast 2020-2026

Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks’ gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.
North America is the largest consumption place, with a consumption market share nearly 33.70% in 2018. Following North America, China is the second largest consumption place with the consumption market share of 26.77% in 2018.
Market Analysis and Insights: Global Respiratory Distress Syndrome Market
In 2019, the global Respiratory Distress Syndrome market size was US$ 371.2 million and it is expected to reach US$ 542.2 million by the end of 2026, with a CAGR of 5.5% during 2021-2026.
Global Respiratory Distress Syndrome Scope and Market Size
Respiratory Distress Syndrome market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Distress Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Respiratory Distress Syndrome market is segmented into Poractant Alfa, Beractant, Calfactant, Others, etc.
Segment by Application, the Respiratory Distress Syndrome market is segmented into Very Preterm Infants, Moderate to Late Preterm Infants, Others, etc.
Regional and Country-level Analysis
The Respiratory Distress Syndrome market is analysed and market size information is provided by regions (countries).
The key regions covered in the Respiratory Distress Syndrome market report are Europe, China, Iran, United States and Korea, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Respiratory Distress Syndrome Market Share Analysis
Respiratory Distress Syndrome market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Respiratory Distress Syndrome business, the date to enter into the Respiratory Distress Syndrome market, Respiratory Distress Syndrome product introduction, recent developments, etc.
The major vendors include Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen, etc.

This report focuses on the global Respiratory Distress Syndrome status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Respiratory Distress Syndrome development in Europe, China, Iran, United States and Korea.

The key players covered in this study


Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
...

Market segment by Type, the product can be split into


Poractant Alfa
Beractant
Calfactant
Others
Poractant Alpha's largest market share is broken down to 67%.

Market segment by Application, split into


Very Preterm Infants
Moderate to Late Preterm Infants
Others
Very Preterm shapes the largest segment of the application market

Market segment by Regions/Countries, this report covers


Europe
China
Iran
United States
Korea

The study objectives of this report are:


To analyze global Respiratory Distress Syndrome status, future forecast, growth opportunity, key market and key players.
To present the Respiratory Distress Syndrome development in Europe, China, Iran, United States and Korea.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Respiratory Distress Syndrome are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions



This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports